This information was published on 2026-07-05T00:07:17 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2632617 (IR 1905861) |
| (220) |
09 Feb 2026
|
| (300) |
GB, 04 Feb 2026, UK00004335278
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical and medicinal preparations and substances; vaccines. |
| (540) | QUDARIZ |
| (550) | Word |
| (730) |
Glaxo Group Limited
|
Find out more about publications on the About page.